This article is part of a Health Affairs Forefront featured series, “Assessing The Evidence For MA Reform.” The series was developed and supported by the research firm, Stage Analytics, through a ...
The Centers for Medicare and Medicaid Services recently sent shudders through the specialty drug market by authorizing Medicare Advantage Plans to use step therapy protocols for Part B drugs. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback